Humana (HUM) Akcija Cena
Humana Cena
Pēdējos 19 gados Humana ieņēmumi auga par 9,9 % gadā un sasniedza 129,66 B USD. Peļņa uz akciju auga par 6,7 % gadā pēdējos 19 gados. Humana neto marža 0,9 % ir samazinājusies salīdzinājumā ar 3,5 % pirms dažiem gadiem. Pie šodienas cenas dividenžu ienesīgums ir aptuveni 0,85 %. Izmaksas koeficients ir ap 36 % no peļņas. Dividendes auga par 11,7 % gadā pēdējos 14 gados. Humana 12 mēnešu konsensa mērķa cena ir 412,50 USD, ap zem kursu par 1,3 %. No 32 analītiķiem 19 iesaka pirkt — kopējais konsenss ir Pirkt.
Humana akcijas cena
Iegūstiet šos datus caur Eulerpool API
100 000 pieprasījumu/mēn. bez maksas · bez kartes
Humana biznesa modelis un akciju analīze
Bieži uzdotie jautājumi par Humana akciju
The business model of Humana Inc is focused on providing healthcare services to individuals and families. As a leading health insurance company, Humana offers a wide range of health insurance plans and services including Medicare, Medicaid, and commercial plans. The company aims to improve the health and wellbeing of its members by offering access to quality healthcare, working closely with healthcare providers, and promoting preventive care and wellness programs. With a strong commitment to innovation and technology, Humana strives to enhance the overall healthcare experience for its members while driving value and affordability in healthcare delivery.
Humana Inc is primarily active in the healthcare industry. With a focus on offering a wide range of health insurance products and services, Humana serves individuals, employers, military service members, and their families. The company provides various medical and specialty health products, including Medicare Advantage plans, prescription drug plans, dental, vision, and wellness programs. With an extensive network of healthcare providers, Humana aims to improve the health and well-being of its members by delivering personalized and comprehensive healthcare solutions. As one of the leading healthcare companies, Humana Inc plays a crucial role in the provision of accessible and quality healthcare services.
The main competitors of Humana Inc in the market include UnitedHealth Group Incorporated, Anthem, Inc., and CVS Health Corporation.
Humana Inc is a leading healthcare company founded in 1961 and headquartered in Louisville, Kentucky. With a rich history spanning over five decades, Humana has emerged as a trusted name in the industry. Originally a nursing home business, Humana quickly expanded its operations to provide comprehensive health insurance services. Today, it offers a wide range of healthcare products and services, including Medicare and Medicaid plans, commercial health insurance, and specialty benefits. Through strategic acquisitions and partnerships, Humana has consistently grown its presence, providing innovative and accessible healthcare solutions to millions of customers across the United States. The company's commitment to customer-centric care and its extensive industry experience have solidified Humana Inc's position as a prominent player in the healthcare sector.
Humana Inc, a renowned healthcare company, has achieved several significant milestones throughout its history. One notable achievement was the company's inclusion in the Fortune 500 list, highlighting its position among the top-ranked businesses in the United States. Additionally, Humana Inc has consistently expanded its presence and diversified its offerings, successfully establishing itself as a leading provider of health insurance, wellness programs, and healthcare services. The company has also been recognized for its commitment to innovation, earning accolades for its progressive approach to healthcare delivery. Humana Inc's dedication to improving customer satisfaction and promoting healthy living has contributed to its widespread success in the industry.
Humana Inc is primarily present in the United States.
Humana Inc is committed to enhancing the well-being of people and making healthcare more accessible. The company's corporate philosophy revolves around delivering value-based care, focusing on the whole person, and improving the health outcomes of its members. Humana prioritizes innovation and technology to provide personalized and affordable healthcare solutions. With a focus on preventive care and wellness programs, Humana aims to empower individuals to live healthier lives. By fostering a culture of inclusion, collaboration, and integrity, Humana strives to be a trusted partner for its members, employees, and communities it serves.
Analītiķi pašlaik nosaka vidējo Humana akcijas mērķa cenu 416,78 USD (mediāna: 412,50 USD), kas ir +3,0 % pret pēdējo cenu. Konsenss balstās uz 32 analītiķu vērtējumiem.
32 analītiķi pašlaik vērtē Humana akciju: 19 iesaka pirkt, 12 turēt un 1 pārdot. 2026. gadam analītiķi sagaida, ka Humana gūs 162,56 B USD ieņēmumus un 9,14 USD peļņu uz akciju.
Pēc pašreizējā kursa Humana akcija maksā 373,34 EUR (417,87 USD).
Humana akcija (HUM) tiek kotēta 7 biržās, tostarp: NYSE (HUM), London (0J6Z.L), SIX (Zürich) (HUM.SW), Frankfurt (HUM.F), München (HUM.MU), Düsseldorf (HUM.DU).
Humana Inc is a global healthcare company based in Louisville, Kentucky. It offers various products and services in healthcare, health insurance, and lifelong health solutions. They provide insurance for different areas such as medical, dental, vision, and travel. Additionally, they have specialized insurance plans for seniors and people with chronic illnesses. Humana also operates clinics and medical centers, offering a wide range of medical services including prevention, diagnosis, and treatment. They invest in research and development of medical technologies to improve healthcare. In terms of lifelong health solutions, Humana has programs like Humana GO365 that reward healthy behaviors. They also operate pharmacies and offer specialized pharmacy services. Humana's business model aims to provide tailored health solutions and insurance products to meet each customer's needs.
gaidāmā apgrozījums Humana ir 162,56 B USD. Šis skaitlis ir balstīts uz pašreizējiem finanšu datiem un atspoguļo uzņēmuma biznesa sniegumu.
gaidāmā peļņa Humana ir 1,10 B USD. Neto peļņa atspoguļo uzņēmuma rentabilitāti pēc visu izdevumu atskaitīšanas.
Humana cenas un peļņas rādītājs (P/E) pašlaik ir 45,73. P/E rādītājs salīdzina pašreizējo akcijas cenu ar peļņu uz akciju un palīdz ieguldītājiem novērtēt Humana akcijas vērtību.
Humana cenas un apgrozījuma rādītājs (P/S) pašlaik ir 0,31. P/S rādītājs salīdzina tirgus kapitalizāciju ar gada apgrozījumu un kalpo kā Humana akcijas vērtības mērs.
Humana Eulerpool kvalitātes rādītājs ir 5/10.
Humana ISIN ir US4448591028. ISIN (International Securities Identification Number) ir pasaulē unikāls vērtspapīru identifikators.
Humana WKN ir 856584. WKN (Wertpapierkennnummer) ir sešciparu vācu vērtspapīru identifikācijas numurs.
Humana tikeris ir HUM. Tikeris tiek izmantots Humana akciju tirdzniecībai biržā.
Humana akcija
Humana Salīdzināmo uzņēmumu grupa
Humana Biržas kods
Humana FIGI
Visi Humana fundamentālie rādītāji un padziļinātā analīze
Mūsu akciju analīze par Humana ietver svarīgus finanšu rādītājus, piemēram, apgrozījumu, peļņu, P/E rādītāju, P/S rādītāju, EBIT, kā arī informāciju par dividendēm. Turklāt mēs aplūkojam aspektus kā akcijas, tirgus kapitalizāciju, parādus, pašu kapitālu un saistības no Humana. Ja meklējat sīkāku informāciju par šīm tēmām, piedāvājam detalizētas analīzes mūsu apakšlapās: